-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on MBX Biosciences Inc (MBX), eyes MBX-4291 GLP Ph.1/2a trial results in Q4
-
-
-
-
-
-
-
MBX Biosciences names Karen Basbaum as chief business officer
-
-
-
-
-
-
-
MBX Biosciences Inc (MBX) PT Raised to $50 at Stifel on PEP Platform Validation
-
-
-
-
-
-
-
Biotech and Medical Tech Stocks Report Breakthrough Clinical Trial Updates
-
-
-
-
-
-
-
Mizuho Starts MBX Biosciences Inc (MBX) at Outperform
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on MBX Biosciences Inc (MBX)
-
-
-
-
-
-
-
MBX Biosciences (MBX) Announces Additions to Leadership Team
-
416,807 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

